Cinacalcet Lowers Serum Alkaline Phosphatase in Maintenance Hemodialysis Patients | Zendy

Vasily Belozeroff | Zendy; William G. Goodman | Zendy; Lulu Ren | Zendy; Kamyar KalantarZadeh | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cinacalcet Lowers Serum Alkaline Phosphatase in Maintenance Hemodialysis Patients

Author(s) -

Vasily Belozeroff,

William G. Goodman,

Lulu Ren,

Kamyar KalantarZadeh

Publication year - 2009

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.03790808

Subject(s) - cinacalcet , medicine , urology , placebo , secondary hyperparathyroidism , hemodialysis , confidence interval , parathyroid hormone , alkaline phosphatase , dialysis , randomized controlled trial , post hoc analysis , hyperparathyroidism , gastroenterology , endocrinology , surgery , calcium , pathology , biochemistry , chemistry , enzyme , alternative medicine

Studies suggest an association between elevated serum alkaline phosphatase (AP) and increased mortality in hemodialysis patients, but the effect of existing therapies on AP is not fully understood. We assessed the effects of cinacalcet on AP in a secondary analysis of controlled trial data.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research